Women
With ICAP’s Collaboration, Eswatini Contributes to Pivotal Multi-Country Study on Contraception and HIV Risk
Results from Eswatini’s first-ever interventional randomized clinical trial, just released, reveal no substantial difference in HIV risk for women using one of three highly effective, reversible methods of contraception. Eswatini’s participation in the multi-country...
(Independent Online) #SAAIDS2019: Results of study on female contraceptives, HIV link to be released
The results of a clinical study that provided evidence about the potential link between three female contraceptives and an increased risk in HIV infection were released at the 9th South African AIDS Conference in Durban on Thursday afternoon. Participants were from...
In Eswatini, ICAP Extends Follow-Up and Testing to Give HIV-Exposed Infants a Healthy Start in Life
For pregnant and breastfeeding women living with HIV, antiretroviral therapy (ART) is a safe and effective way to avoid transmitting HIV to their babies. Strategies like Option B+, where expectant mothers living with HIV are offered lifelong ART regardless of their...